Interactions between long-acting antiretrovirals and opioids: a call for clinical awareness
Clinical Microbiology Reviews · 11.06.2026 · 39 (2)
DOI: 10.1128/cmr.00395-25 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Clinical Microbiology Reviews, erschienen am 11.06.2026. Verfasst von Candy Carbajal und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cellular and Molecular Medicine, Herbert Wertheim College of Medicine, Florida International University, Miami, Florida, USA. Hauptthemen laut MEDLINE: Analgesics, Opioid, HIV Infections, Anti-HIV Agents. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 134 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDA NIH HHS, NIH HHS, National Institutes of Health.
Abstract (Originalsprache)
This review summarizes potential drug-drug interactions (DDIs) between long-acting antiretrovirals (LAAs) and opioids, focusing on pharmacodynamics (PD), pharmacokinetics (PK), and side effects related to absorption, distribution, metabolism, and excretion (ADME). It also covers dysregulation in epigenetics and in the immune system. A comprehensive literature review was performed using PubMed and Google Scholar, along with data from the Liverpool HIV Drug Interactions Database, to evaluate pharmacokinetic interactions between LAA drugs, such as cabotegravir, rilpivirine, lenacapavir, and dapivirine, with opioids used in clinical settings, including morphine, tramadol, oxycodone, and codeine; medications for opioid use disorder (MOUD), such as methadone and buprenorphine; and the illicit opioids, including fentanyl and heroin. The review highlights key factors increasing DDI risk and discusses clinical considerations for managing preexposure prophylaxis (PrEP) or antiretroviral therapy (ART) in persons who use opioids. Lastly, it proposes research strategies for studying DDIs, including the use of animal models, physiologically based pharmacokinetic (PBPK) models, and clinical trials.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cellular and Molecular Medicine, Herbert Wertheim College of Medicine, Florida International University, Miami, Florida, USA.
- Department of Chemistry and Biochemistry, College of Arts and Sciences, Florida International University, Miami, Florida, USA.
- Center For Translational Science, Florida International University, Miami, Florida, USA.
- Department of Pharmacology and Experimental Neuroscience, University of Nebraska Medical Center, Omaha, Nebraska, USA.
ORCID-Profile: Candy Carbajal, Nazira El-Hage
Förderung
- NIDA NIH HHS
- NIH HHS
- National Institutes of Health
Zitieren
APA
Carbajal, C., Owens, F., Veeragoni, D., Rodriguez, M., Fernandez-Lima, F., Nefzi, A., Buch, S., & El-Hage, N. (2026). Interactions between long-acting antiretrovirals and opioids: a call for clinical awareness. Clinical Microbiology Reviews, 39(2). https://doi.org/10.1128/cmr.00395-25
Vancouver
Carbajal C, Owens F, Veeragoni D, Rodriguez M, Fernandez-Lima F, Nefzi A, et al. Interactions between long-acting antiretrovirals and opioids: a call for clinical awareness. Clinical Microbiology Reviews. 2026;39(2). doi:10.1128/cmr.00395-25
BibTeX
@article{Carbajal2026,
author = {Carbajal, Candy and Owens, Florida and Veeragoni, Dileepkumar and Rodriguez, Myosotys and Fernandez-Lima, Francisco and Nefzi, Adel and Buch, Shilpa and El-Hage, Nazira},
title = {Interactions between long-acting antiretrovirals and opioids: a call for clinical awareness},
journal = {Clinical Microbiology Reviews},
year = {2026},
volume = {39},
number = {2},
doi = {10.1128/cmr.00395-25}
}
EUVIMED